1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
NCT01791387
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER_GOV
Sponsor class
Conditions
Clear Cell Renal Cell Carcinoma
Interventions
DRUG:
Dovitinib
Sponsor
Auckland District Health Board
Collaborators
[object Object]
[object Object]
[object Object]